Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cleveland, Ohio
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- Delaware
- Filings on record
- 1,003+ filings
- On EDGAR
- CIK 318306
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 76
News 8 of 206
- 8-K Quarterly results Nov 9, 2026
- 8-K Significant contract Nov 9, 2026
- 8-K Current report on a material event Sep 15, 2026
- 8-K Quarterly results Aug 13, 2026
- 8-K Shareholder vote results Jun 12, 2026
- 8-K Leadership change Jun 12, 2026
- 8-K Current report on a material event Jun 10, 2026
- 8-K Other events Jun 4, 2026
Prospectuses and Registrations 8 of 80
- 424B3 Prospectus supplement for an offering Jul 10, 2026
- S-8 Registration statement for an employee plan Jun 26, 2026
- S-8 Registration statement for an employee plan Jan 6, 2025
- 424B5 Prospectus supplement for an offering Jun 21, 2024
- S-3/A Shelf registration statement, amended Jun 17, 2024
- S-3 Shelf registration statement Jun 12, 2024
- S-8 Registration statement for an employee plan May 15, 2024
- 424B5 Prospectus supplement for an offering May 3, 2024
Proxies 8 of 32
- DEFA14A Extra proxy material May 4, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- PRE 14A Preliminary proxy statement Apr 17, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 9, 2025
- DEF 14A Proxy statement for a shareholder vote Nov 12, 2024
- DEF 14A Proxy statement for a shareholder vote Mar 19, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 13, 2023
- DEFA14A Extra proxy material Aug 4, 2022
Ownership 8 of 514
- SCHEDULE 13D Large holder reported an active stake Oct 23, 2026
- 4 Insider reported a trade Sep 29, 2026
- 4 Insider reported a trade Sep 29, 2026
- 4 Insider reported a trade Sep 29, 2026
- 4 Insider reported a trade Sep 29, 2026
- 144 Notice of a proposed sale of restricted stock Sep 29, 2026
- 144 Notice of a proposed sale of restricted stock Sep 29, 2026
- 144 Notice of a proposed sale of restricted stock Sep 29, 2026
Other 8 of 95
- ARS Annual report sent to shareholders Apr 27, 2026
- EFFECT Notice that a registration became effective Jun 20, 2024
- CORRESP Reply to SEC staff Jun 17, 2024
- ARS Annual report sent to shareholders Apr 19, 2023
- EFFECT Notice that a registration became effective Dec 12, 2022
- CORRESP Reply to SEC staff Dec 6, 2022
- UPLOAD Comment letter from SEC staff Dec 5, 2022
- EFFECT Notice that a registration became effective Oct 22, 2021
Everything here comes from Abeona Therapeutics Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.